| Literature DB >> 31421902 |
Yi Fan1.
Abstract
Angiogenesis is a hallmark of cancer. However, current antivascular therapies that primarily target angiogenic factors have faced difficulties and failures in treating most cancers. It is proposed that endothelial transformation acts as an alternative driver of excessive and abnormal vascularity that fuels cancer progression and immunosuppression, and also induces resistance to therapy. Thus, vascular detransformation may serve as a promising therapeutic strategy against cancer.Entities:
Keywords: angiogenesis; antivascular therapy; cancer; endothelial transformation; endothelial–mesenchymal transition
Mesh:
Substances:
Year: 2019 PMID: 31421902 PMCID: PMC7252212 DOI: 10.1016/j.trecan.2019.05.007
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025